The Latest
Investor Profile

External equity: A worry at Wellcome

The £26.8 billion Wellcome Trust continues to reduce its allocation to external equities managers as the investment committee focuses on currency exposures, ESG and hedge funds,the impact of low interest rates and the position of the credit cycle in 2020.
Sarah RundellJanuary 20, 2020
Analysis

Post-Brexit uncertainty reigns

‘Selective optimism’ in UK real estate, infrastructure and other assets characterises investors across Europe as they scramble to tell the genuine opportunities from fool’s gold following Brexit.
Sarah RundellMarch 15, 2017
Opinion

G7 agreement shows benefits of engaging policymakers

Fiona Reynolds, managing director at the Principles for Responsible Investment (PRI) discusses why it’s in everyone’s interests for more investor voices to be heard between now and November before the world’s nations converge at COP21 in Paris.   The announcement that the G7 leading industrial nations have agreed to cut greenhouse gases by phasing out the use of […]
Amanda WhiteJuly 1, 2015
Opinion

The investment model for asset owners: is there a best-practice version?

In the last of a series of articles exclusively for www.top1000funds.com, Roger Urwin, head of global content at Towers Watson examines the asset owner investment models that are recognised as best practice, questioning whether there are patterns to the models of success. The best-practice investing model could either involve how you do it or what […]
Ghost Top1000August 27, 2014
Analysis

Fewer, bigger funds for UK?

Australia, the US, Canada and Denmark have all done it. Kazakhstan and even Oman are talking about it. Increasingly, public sector pension funds are merging or pooling their assets into fewer bigger schemes. It’s no surprise the debate is gathering momentum in the United Kingdom, ripe for consolidation with a Local Government Pension Fund Scheme […]
Sarah RundellJune 7, 2013
Investor Profile

Illiquid medicine brings rude health to the Wellcome Trust

Sir Henry Wellcome, the early twentieth century pharmaceuticals magnate (pictured below), would be pleased with how well the London-based charitable foundation that bears his name has weathered the global downturn. The Wellcome Trust (WT), which supports medical research in Britain and around the world, reported a total return of 12 per cent for the year […]
Richard TomlinsonJanuary 18, 2013